Aishi Bera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aishi Bera has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ankita Chowdhury
Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India
1 shared publication - Anushka Dutta
Department of Biotechnology, Heritage Institute of Technology, Kolkata 700107, West Bengal, India
1 shared publication - Anuvab Dey
Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, North Guwahati 781039, Assam, India
1 shared publication - Atharva Anand Mahajan
Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai 410210, Maharashtra, India
1 shared publication - Indrilla Ghose
Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM), Dhanbad 826004, Jharkhand, India
1 shared publication - Ipsita Majumder
Department of Biotechnology, Heritage Institute of Technology, Kolkata 700107, West Bengal, India
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 31 March 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (4) , 365
Beta-Glucans in Biotechnology: A Holistic Review with a Special Focus on Yeast
Beta-glucans (β-glucans) are polysaccharides with significant biological activity, widely recognized for their immunomodulatory, anti-inflammatory, and metabolic health benefits. Among various sources, yeast-derived β-(1 → 3), (1 → 6)-glucans have gained particular attention due to their potent bioactivity and diverse applications in biotechnology, pharmaceuticals, and functional foods. This review comprehensively examines yeast β-glucans, covering their biosynthesis, extraction, and purification from industrially relevant yeast strains, particularly Saccharomyces cerevisiae. The impact of fermentation parameters on β-glucan yield and structural properties is analyzed, highlighting advancements in optimizing microbial production. Furthermore, we discuss methods for characterizing yeast β-glucans, including analytical and bioassay techniques, and compare their physicochemical properties with those of β-glucans from other sources. Finally, this review explores the therapeutic potential of yeast-derived β-glucans, focusing on their role in immunomodulation and metabolic regulation and their emerging applications in biomedicine, functional foods, and industrial formulations. By synthesizing recent advancements, this work provides insights into the expanding utilization of yeast β-glucans and their potential for future biotechnological developments.
- 31 March 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (4) , 365
Top Cited PapersOpen AccessBeta-Glucans in Biotechnology: A Holistic Review with a Special Focus on Yeast
Beta-glucans (β-glucans) are polysaccharides with significant biological activity, widely recognized for their immunomodulatory, anti-inflammatory, and metabolic health benefits. Among various sources, yeast-derived β-(1 → 3), (1 → 6)-glucans have gained particular attention due to their potent bioactivity and diverse applications in biotechnology, pharmaceuticals, and functional foods. This review comprehensively examines yeast β-glucans, covering their biosynthesis, extraction, and purification from industrially relevant yeast strains, particularly Saccharomyces cerevisiae. The impact of fermentation parameters on β-glucan yield and structural properties is analyzed, highlighting advancements in optimizing microbial production. Furthermore, we discuss methods for characterizing yeast β-glucans, including analytical and bioassay techniques, and compare their physicochemical properties with those of β-glucans from other sources. Finally, this review explores the therapeutic potential of yeast-derived β-glucans, focusing on their role in immunomodulation and metabolic regulation and their emerging applications in biomedicine, functional foods, and industrial formulations. By synthesizing recent advancements, this work provides insights into the expanding utilization of yeast β-glucans and their potential for future biotechnological developments.